ABSTRACT
Fifty years of evolution in infection prevention and control programs have involved significant accomplishments related to clinical practices, methodologies, and technology. However, regulatory mandates, and resource and research limitations, coupled with emerging infection threats such as the COVID-19 pandemic, present considerable challenges for infection preventionists. This article provides guidance and recommendations in 14 key areas. These interventions should be considered for implementation by United States health care facilities in the near future.
Subject(s)
COVID-19 , Cross Infection , Humans , United States , Cross Infection/prevention & control , Cross Infection/epidemiology , Pandemics/prevention & control , COVID-19/prevention & control , Health Facilities , Infection Control/methodsABSTRACT
The Certification Board of Infection Control and Epidemiology conducted a marketing research study to determine the perceived value of the certification in infection prevention and control among infection prevention professionals and other stakeholders. Four thematic categories were identified: certification process and standards; professionalism, competency, and career growth; patient care, safety, infection prevention and control; and regulatory compliance. Respondents stated that certification demonstrated professional competency, increased career growth, improved regulatory compliance, was important in influencing legislation, and improved the practice of infection prevention and control. Opportunities were to reevaluate eligibility criteria and examination difficulty; demonstrate how certification increases financial compensation and organizational recognition; and offer recertification through continuing education based on the study findings, strategic recommendations and next steps were incorporated into the strategic plan. This article is an overview and summarizes the study findings.
